Relative contraindications requiring caution include active or suspected cancer (GHK-Cu promotes angiogenesis with concern about theoretically feeding tumors, though conflicting data shows documented anti-cancer gene expression effects requiring medical supervision), severe organ dysfunction (kidney or liver failure may slow peptide clearance), hemochromatosis or copper overload conditions, autoimmune disorders, and patients on immunosuppressants or blood thinners
Not all patients are appropriate candidates for peptide therapy
As obesity is a major risk factor for various health complications, the introduction of Tirzepatide represents a significant advancement in the treatment landscape for individuals struggling with both diabetes and obesity
Results can vary widely depending on the individual, their lifestyle habits, overall health, and whether theyre pairing therapy with nutrition, exercise, sleep, and strength training
While some findings are intriguing, they are far from conclusive, especially when it comes to human use
Those who did not receive enough were associated with a much higher risk for obesity